COVID-19 NOTIFICATION: To protect your safety in response to the threat of COVID-19, our staff is still available to serve you during our normal office hours. We are offering our clients and potential clients the option to connect with us via telephone, email and video-conferencing. Please call or email us to discuss your options.

AHP issues recall of defective product due to mislabeling

| Jul 25, 2014 | Dangerous Or Defective Products

Ibuprofen tablets are used to treat general pain, and also the pain associated with osteoarthritis and rheumatoid arthritis. A voluntary recall has been issued by American Health Packaging in regard to Ibuprofen tablets being issued to West Virginia patients and other patients throughout the country. Reportedly, the hospital dose is a defective product, which may have individual blistered doses that are labeled as Oxcarbazepine. This is caused by a mislabeled inner unit blister packaging.

Reportedly, the mislabeling could cause patients to miss their dose of oxycarbazepine. The drug is used to treat epileptic patients who suffer from certain seizures. Patients who do not receive their scheduled dose of oxycarbazepine stand the risk of having a seizure. So far, American Health Packaging has received one complaint, which is what led to the recall.

At this time, there have been no reports of a negative event in regard to the drug due to the mislabeling. The recall notice has been sent to companies that have received the defective product. Patients who have the product are advised to stop using it and to contact GENCO Pharmaceutical Services as soon as possible.

Defective products can cause consumers to experience injuries and, in some cases, death. The recall was done as a safety precaution, and patients who have experienced adverse reactions or injuries due to the defective product may have the right to initiate product liability claims against the manufacturer. Family members of deceased patients may also have similar rights under our West Virginia wrongful death laws. Being proactive and filing claims could result in financial compensation that is well-deserved.

Source:, “Recall Alert: Hospital unit dose ibuprofen, oxcarbazepine“, , July 18, 2014